Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

NRG Therapeutics Selects First Development Candidate, NRG5051, and Secures Grant from The Michael J. Fox Foundation for Development of mPTP Inhibitors to Treat Neurodegenerative Diseases

• First development candidate selected, NRG5051, with potential to treat Parkinson’s and Amyotrophic Lateral Sclerosis (ALS) (also known as Motor Neuron Disease, MND) and other neurodegenerative diseases
• NRG5051 prevents mitochondrial dysfunction via inhibition of the mitochondrial permeability transition pore (mPTP) through a novel protein target
• Inhibition of the mPTP in the brain prevents neuronal cell death and reduces neuroinflammation in animals
• $5M grant from The Michael J. Fox Foundation (MJFF) to advance NRG5051 into the clinic

Postdoctoral Fellow – Birney Research

This is an exciting opportunity to get involved in a research project building upon innovative AI approaches to define gene x drug exposure x phenotype relationships at scale over continuous time in large human cohorts. We are looking for a highly motivated bioinformatics expert or data scientist to join this exciting project, and to drive specific aspects of this cutting-edge research, including the analysis of population scale genetic cohorts with electronic healthcare and prescriptions records.

Entries Open for the One Nucleus Annual Awards 2025!

Following the success of this year’s Awards, with feedback indicating it brought something new and inclusive to the ecosystem, One Nucleus is delighted to announce our Annual Awards 2025.

The continued success of the Life Sciences sector is built on the excellence of all its stakeholders hence One Nucleus feels we should celebrate by recognising all parts of our community including life science innovators, R&D companies, non-profit organisations, technical providers and professional advisors.

Operations Director

An exciting opportunity to lead the Operations Team at Stevenage Bioscience Catalyst, an award-winning location for companies to start-up, scale-up and commercialise therapeutic innovations in the centre of the golden triangle.

About Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst co-located on the Elevate Quarter Campus in Stevenage with a focus on providing accommodation and support to help companies develop and commercialise cutting edge therapeutics.

Innovative Essex Health Projects Get Cash Boost

Funding from Anglia Ruskin University is helping small firms' cutting-edge initiatives

Virtual reality therapy for people suffering from mental health disorders, using AI to manage demand on NHS services, and technology that listens to a child’s cough to assist early diagnoses are among the Essex innovations that have received thousands of pounds of funding from Arise Innovation Hubs – part of Anglia Ruskin University (ARU).

Ikarovec’s Seed Round Extension Brings Total to £8m With Proceeds to Advance Lead Sight Loss Programme Towards Clinic

  • Funds raised to continue advanced pre-clinical trials of novel gene therapies to treat blindness and major chronic eye disease
  • Led by LifeArc Ventures and Parkwalk Advisors, with participation from the UK Innovation, Science and Seed Fund, managed by Future Planet Capital (UKI2S)
  • Dr Jean-Philippe Combal of Vivet Therapeutics and SpliceBio appointed as NED
Subscribe to